Lingxin Meng

State Key Laboratory Of Vaccines For Infectious Diseases, 4221-116 Xiang'An South Rd
Xiamen, 361102, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Modification of Asp-Peptide Adapters: Giving the FAP-Targeted Radioligand a "Squirrel Tail".

Modification of Asp-Peptide Adapters: Giving the FAP-Targeted Radioligand a "Squirrel Tail".

Journal: Journal of medicinal chemistry

Published: March 18, 2025

Development of radioligands with an albumin-binding moiety of 4-(P-Iodophenyl) butyric acid for theranostic applications.

Development of radioligands with an albumin-binding moiety of 4-(P-Iodophenyl) butyric acid for theranostic applications.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 28, 2024

FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics.

FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 04, 2024

Rational Design and Pharmacomodulation of 18F-Labeled Biotin/FAPI-Conjugated Heterodimers.

Rational Design and Pharmacomodulation of 18F-Labeled Biotin/FAPI-Conjugated Heterodimers.

Journal: Journal of medicinal chemistry

Published: May 10, 2024

Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types.

Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types.

Journal: Journal of medicinal chemistry

Published: May 08, 2024

18F-Labeled Amidobenzimidazole Analogue for Visualizing STING Expression in Tumor.

18F-Labeled Amidobenzimidazole Analogue for Visualizing STING Expression in Tumor.

Journal: Molecular pharmaceutics

Published: March 06, 2024

Preclinical Evaluation of 131I/18F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging.

Preclinical Evaluation of 131I/18F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging.

Journal: ACS pharmacology & translational science

Published: December 31, 2023

Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy.

Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 15, 2023

Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression.

Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 25, 2022

Synthesis and Preclinical Evaluation of a 68Ga-Labeled Pyridine-Based Benzamide Dimer for Malignant Melanoma Imaging.

Synthesis and Preclinical Evaluation of a 68Ga-Labeled Pyridine-Based Benzamide Dimer for Malignant Melanoma Imaging.

Journal: Molecular pharmaceutics

Published: December 23, 2022

Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.

Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.

Journal: Molecular pharmaceutics

Published: August 02, 2022

Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein.

Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein.

Journal: Journal of medicinal chemistry

Published: June 06, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026